FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111900955> ?p ?o ?g. }

• W2111900955 endingPage "595" @default.
• W2111900955 startingPage "589" @default.
• W2111900955 abstract "Purpose This study aimed to evaluate the efficiency and the tolerance of radiation therapy (RT) on salivary glands in a large series of amyotrophic lateral sclerosis (ALS) patients with hypersalivation. Methods and Materials Fifty ALS patients that had medically failure pretreatment were included in this prospective study. RT was delivered through a conventional linear accelerator with 6-MV photons and 2 opposed beams fields including both submandibular glands and two-thirds of both parotid glands. Total RT dose was 10 Gy in 2 fractions (n=30) or 20 Gy in 4 fractions (n=20). RT efficacy was assessed with the 9-grade Sialorrhea Scoring Scale (SSS), recently prospectively validated as the most effective and sensitive tool to measure sialorrhea in ALS patients. Results At the end of RT, all patients had improved: 46 had a complete response (92% CR, SSS 1-3) and 4 had a partial response (8% PR, SSS 4-5). A significant lasting salivary reduction was observed 6 months after RT completion: there was 71% CR and 26% PR, and there was a significant SSS reduction versus baseline (P<10−6). There was no grade 3 to 4 toxicity, and most side effects (34%) occurred during RT. Nine patients (18%) underwent a second salivary gland RT course, with a 3-months mean delay from the first RT, resulting in a SSS decrease (−77%). Both RT dose regimens induced a significant SSS decrease with no significant toxicity. There were, however, more patients with CR/PR in the 20-Gy protocol (P=.02), and 8 of 9 patients (89%) receiving a second RT course had previously been treated within the 10-Gy protocol. Conclusion Radiation therapy of 20 Gy in 4 fractions is an efficient and safe treatment for ALS patients with sialorrhea. A shorter RT course (10 Gy in 2 fractions) may be proposed in patients in poor medical condition. This study aimed to evaluate the efficiency and the tolerance of radiation therapy (RT) on salivary glands in a large series of amyotrophic lateral sclerosis (ALS) patients with hypersalivation. Fifty ALS patients that had medically failure pretreatment were included in this prospective study. RT was delivered through a conventional linear accelerator with 6-MV photons and 2 opposed beams fields including both submandibular glands and two-thirds of both parotid glands. Total RT dose was 10 Gy in 2 fractions (n=30) or 20 Gy in 4 fractions (n=20). RT efficacy was assessed with the 9-grade Sialorrhea Scoring Scale (SSS), recently prospectively validated as the most effective and sensitive tool to measure sialorrhea in ALS patients. At the end of RT, all patients had improved: 46 had a complete response (92% CR, SSS 1-3) and 4 had a partial response (8% PR, SSS 4-5). A significant lasting salivary reduction was observed 6 months after RT completion: there was 71% CR and 26% PR, and there was a significant SSS reduction versus baseline (P<10−6). There was no grade 3 to 4 toxicity, and most side effects (34%) occurred during RT. Nine patients (18%) underwent a second salivary gland RT course, with a 3-months mean delay from the first RT, resulting in a SSS decrease (−77%). Both RT dose regimens induced a significant SSS decrease with no significant toxicity. There were, however, more patients with CR/PR in the 20-Gy protocol (P=.02), and 8 of 9 patients (89%) receiving a second RT course had previously been treated within the 10-Gy protocol. Radiation therapy of 20 Gy in 4 fractions is an efficient and safe treatment for ALS patients with sialorrhea. A shorter RT course (10 Gy in 2 fractions) may be proposed in patients in poor medical condition." @default.
• W2111900955 created "2016-06-24" @default.
• W2111900955 creator A5004501662 @default.
• W2111900955 creator A5006151659 @default.
• W2111900955 creator A5007104934 @default.
• W2111900955 creator A5013942703 @default.
• W2111900955 creator A5016990492 @default.
• W2111900955 creator A5022219267 @default.
• W2111900955 creator A5035993217 @default.
• W2111900955 creator A5052734844 @default.
• W2111900955 creator A5057953137 @default.
• W2111900955 creator A5067355239 @default.
• W2111900955 creator A5070798104 @default.
• W2111900955 date "2014-03-01" @default.
• W2111900955 modified "2023-10-16" @default.
• W2111900955 title "Radiation Therapy for Hypersalivation: A Prospective Study in 50 Amyotrophic Lateral Sclerosis Patients" @default.
• W2111900955 cites W1983734876 @default.
• W2111900955 cites W1996486145 @default.
• W2111900955 cites W1999424768 @default.
• W2111900955 cites W2023562457 @default.
• W2111900955 cites W2024886491 @default.
• W2111900955 cites W2051343475 @default.
• W2111900955 cites W2069904844 @default.
• W2111900955 cites W2071254848 @default.
• W2111900955 cites W2075709737 @default.
• W2111900955 cites W2082158279 @default.
• W2111900955 cites W2105512199 @default.
• W2111900955 cites W2106667811 @default.
• W2111900955 cites W2110919338 @default.
• W2111900955 cites W2111758059 @default.
• W2111900955 cites W2118223861 @default.
• W2111900955 cites W2140248514 @default.
• W2111900955 cites W2161938104 @default.
• W2111900955 cites W2167423008 @default.
• W2111900955 cites W2171966382 @default.
• W2111900955 doi "https://doi.org/10.1016/j.ijrobp.2013.11.230" @default.
• W2111900955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24411632" @default.
• W2111900955 hasPublicationYear "2014" @default.
• W2111900955 type Work @default.
• W2111900955 sameAs 2111900955 @default.
• W2111900955 citedByCount "42" @default.
• W2111900955 countsByYear W21119009552014 @default.
• W2111900955 countsByYear W21119009552015 @default.
• W2111900955 countsByYear W21119009552016 @default.
• W2111900955 countsByYear W21119009552017 @default.
• W2111900955 countsByYear W21119009552018 @default.
• W2111900955 countsByYear W21119009552019 @default.
• W2111900955 countsByYear W21119009552020 @default.
• W2111900955 countsByYear W21119009552021 @default.
• W2111900955 countsByYear W21119009552022 @default.
• W2111900955 countsByYear W21119009552023 @default.
• W2111900955 crossrefType "journal-article" @default.
• W2111900955 hasAuthorship W2111900955A5004501662 @default.
• W2111900955 hasAuthorship W2111900955A5006151659 @default.
• W2111900955 hasAuthorship W2111900955A5007104934 @default.
• W2111900955 hasAuthorship W2111900955A5013942703 @default.
• W2111900955 hasAuthorship W2111900955A5016990492 @default.
• W2111900955 hasAuthorship W2111900955A5022219267 @default.
• W2111900955 hasAuthorship W2111900955A5035993217 @default.
• W2111900955 hasAuthorship W2111900955A5052734844 @default.
• W2111900955 hasAuthorship W2111900955A5057953137 @default.
• W2111900955 hasAuthorship W2111900955A5067355239 @default.
• W2111900955 hasAuthorship W2111900955A5070798104 @default.
• W2111900955 hasConcept C126322002 @default.
• W2111900955 hasConcept C141071460 @default.
• W2111900955 hasConcept C148699463 @default.
• W2111900955 hasConcept C188816634 @default.
• W2111900955 hasConcept C2778937882 @default.
• W2111900955 hasConcept C2779134260 @default.
• W2111900955 hasConcept C2779998641 @default.
• W2111900955 hasConcept C2780596555 @default.
• W2111900955 hasConcept C2909146933 @default.
• W2111900955 hasConcept C29730261 @default.
• W2111900955 hasConcept C2989005 @default.
• W2111900955 hasConcept C42219234 @default.
• W2111900955 hasConcept C509974204 @default.
• W2111900955 hasConcept C71924100 @default.
• W2111900955 hasConceptScore W2111900955C126322002 @default.
• W2111900955 hasConceptScore W2111900955C141071460 @default.
• W2111900955 hasConceptScore W2111900955C148699463 @default.
• W2111900955 hasConceptScore W2111900955C188816634 @default.
• W2111900955 hasConceptScore W2111900955C2778937882 @default.
• W2111900955 hasConceptScore W2111900955C2779134260 @default.
• W2111900955 hasConceptScore W2111900955C2779998641 @default.
• W2111900955 hasConceptScore W2111900955C2780596555 @default.
• W2111900955 hasConceptScore W2111900955C2909146933 @default.
• W2111900955 hasConceptScore W2111900955C29730261 @default.
• W2111900955 hasConceptScore W2111900955C2989005 @default.
• W2111900955 hasConceptScore W2111900955C42219234 @default.
• W2111900955 hasConceptScore W2111900955C509974204 @default.
• W2111900955 hasConceptScore W2111900955C71924100 @default.
• W2111900955 hasIssue "3" @default.
• W2111900955 hasLocation W21119009551 @default.
• W2111900955 hasLocation W21119009552 @default.
• W2111900955 hasOpenAccess W2111900955 @default.
• W2111900955 hasPrimaryLocation W21119009551 @default.
• W2111900955 hasRelatedWork W2039437468 @default.
• W2111900955 hasRelatedWork W2111900955 @default.

• next